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New ﬂuorogenic enzyme substrates were synthesized by the coupling of aminonaphthalenesul-
fonamides or 6-hydrazinobenz[de]isoquinoline-1,3-diones with b-alanine. The 6-hydrazinobenz[de]iso-
quinoline-1,3-diones were also condensed with a range of aryl aldehydes to give the corresponding
hydrazones. The photophysical properties of the synthesized amines and hydrazines and their amide,
hydrazide and hydrazone derivatives, were examined and they were also incorporated into Columbia
agar in order to determine their potential for the detection of pathogenic bacteria.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Antimicrobial resistance has been a major obstacle to the
effective treatment of bacterial infections for several decades and
has recently become a serious threat to global public health,
contributing to over 720,000 potentially preventable healthcare-
associated infections (HAIs) in the US p.a. [1] and more than
177,000 p.a. in Australia [2]. Although a natural phenomenon,
antimicrobial resistance has been accelerated by the misuse of
antimicrobial agents, allied to a lack of new agents to replace those
which have become ineffective (only two truly novel antibacterial
agents have been approved in the last 30 years). Antibiotic stew-
ardship programs have been introduced worldwide in attempts to
improve patient outcomes, reduce adverse sequelae associated
with antimicrobial use, and to preserve the ever more limited array
of antibacterials which infectious disease clinicians have at their
disposal [3,4]. In addition, effective prevention and control of
infection can help to reduce the spread of antibiotic resistance, andþ61 2 9351 4391.
(P.W. Groundwater).
Ltd. This is an open access article uthis can be informed by universal screening protocols [5], which are
ideally based upon rapid, simple, and cost-effective techniques for
the detection and identiﬁcation of pathogenic bacteria.
One of the most commonly employed techniques for the
detection and identiﬁcation of bacteria involves the use of chro-
mogenic culture media [6], which employ an initially non-coloured
substrate, consisting of an enzyme-targeting moiety covalently
attached to a chromogen. In the presence of an enzyme which is
speciﬁc to a particular bacterium, the covalent bond is cleaved,
releasing the chromogen, Fig. 1, and thus allowing the detection
and identiﬁcation of this bacterium.
For example, chromID™ Pseudomonas aeruginosa, exploits b-
alanyl-1-pentyl resorufamine 1, which is cleaved by b-alanyl
aminopeptidase to give the chromogen 1-pentylresorufamine 2,
Fig. 1, to enable the rapid identiﬁcation of P. aeruginosa in patients
with cystic ﬁbrosis before conversion into a difﬁcult-to-treat
mucoid phenotype [7]. Other chromogenic media have been
employed for the detection of multi-resistant organisms, such as
methicillin-resistant Staphylococcus aureus (e.g. CHROMagar™
MRSA) [9], vancomycin-resistant enterococci (e.g. VRE-BMX) [10],
and NDM-1 (carbapenemase) producing Enterobacteriaceae [11].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Illustration of the principle for the chromogenic/ﬂuorogenic detection of bacteria and the basis of the colour change in chromID P. aeruginosa [7,8].
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identiﬁcation, a limiting factor in the use of chromogenic media is
the time taken (typically 24e48 h) for the development of sufﬁcient
quantities of the indicative colour of the chromogen, which is
essential for reliable detection against the usually lightly coloured
background. This limitation can be addressed through the devel-
opment of ﬂuorogenic media, since the detection of ﬂuorescence is
inherently more sensitive than the perception of colour change d
media containing ﬂuorogenic substrates should lead to a reduction
in the time required for bacterial detection [12].
In order to develop ﬂuorogenic media for the detection of bac-
teria, the reliable detection of the enzymatically-released ﬂuo-
rophores is necessary, and this can be facilitated by two methods;
(i) an off-to-on mechanism analogous to chromogenic media or (ii)
as the result of a signiﬁcant change in the observed ﬂuorescent
emission wavelengths between the substrate and subsequent ﬂu-
orogen. In addition to displaying intense ﬂuorescence, the ideal
ﬂuorogen should be non-growth inhibitory and retained within
bacterial cells/colonies, while the substrate should be water soluble
and readily taken up by bacterial cells.
Based on their reported ﬂuorescent properties, we identiﬁed
aminonaphthalenesulfonamide (ANS) and 6-hydrazinobenz[de]
isoquinoline-1,3-dione (6-HBI) cores as potential ﬂuorogens
for the detection of bacterial enzymes, Fig. 2. Amino-
naphthalenesulfonamides (ANS) have previously been reported
as useful ﬂuorogenic substrates for proteolytic enzymes involvedFig. 2. Chemical structures and reported excitation and emission wavelengths for core
heterocycles, ANS and 6-HBI.in ﬁbrinolysis and blood coagulation, and the quantitation of Lys-
plasmin [13]. Similarly, benz[de]isoquinoline-1,3-diones have
been used as enzymatic markers for dipeptidyl peptidase IV and
tripeptidyl peptidase I activity in rodents [14], as a probe for
nitroreductase activity for the detection of hypoxic cells [15,16],
and as a marker for the detection of Mycobacterium tuberculosis
[17].
In order to evaluate their potential for the detection of bacteria
in clinical samples, various derivatives of both sets of ﬂuorescent
cores were designed, synthesized and coupled to a suitable amino
acid. b-Alanine was initially chosen as the amino acid moiety in
order to demonstrate the utility of these ﬂuorogens in bacterial
systems by targeting the b-alanyl aminopeptidase activity of
P. aeruginosa. The hydrolysis of the amide bond in the presence of
this bacterium would result in the release of the ﬂuorogen. In the
case of the 6-HBI core, a secondary reaction, with a range of para-
substituted benzaldehydes and cinnamaldehyde, was also envis-
aged in order to enhance the ﬂuorescence observed as a result of
the extension of the conjugation. Both ﬂuorescent core molecules
would be modiﬁed through the introduction of substituents with
different alkyl (R) chain lengths in order to ascertain the optimum
uptake, adherence, and lack of growth inhibition.
Synthesis of the desired ﬂuorophores was ﬁrst achieved using
the methods described below and their subsequent coupling to
Boc-b-alanine was achieved with the same symmetrical anhydride
method for both core molecules.2. Experimental
2.1. General
All reagents and solvents were purchased from SigmaeAldrich,
Alfa Aesar, and ChemSupply, and used without any further puriﬁ-
cation or treatment. Thin layer chromatography was performed on
Grace Reveleris® Silica Aluminum-backed TLC Plates (UV254). 1H
and 13C NMR spectrawere acquired on a Varian 400MR at 400 MHz
and 100 MHz, respectively. Coupling constants (J) are in Hertz (Hz),
chemical shifts (d) are expressed in parts per million (ppm) and
reported relative to residual solvent peaks. Melting points were
obtained on a Stuart Scientiﬁc SMP 10. Low resolution mass spectra
were obtained on TSQ Quantum Access Max (Triple Quadrupole)
LCMS/MS in positive ion mode. High resolution mass spectra were
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Mass Spectrometer (FTICR) in positive ion mode. Infrared spectra
were recorded on a Shimadzu FTIR-8400S and Shimadzu IRTracer-
100. Elemental analyses were obtained from the Campbell Micro-
analytical Laboratory in the University of Otago, NZ.
2.2. General procedure for the preparation of acetamides 6aee
Imide 4 was prepared by the method of Xu et al. [18] and sul-
fonyl chloride 5 by the method of Guan et al. [19].
To a solution of 5 (1 equiv.) in DCM, triethylamine (2 equiv.) and
the appropriate amine (1.5 equiv.) were added. The resulting so-
lution was then left to stir at room temperature overnight. Upon
completion, the organic layer was washed with 1 M HCl
(3  20 mL), water (3  20 mL) and brine (3  20 mL), then dried
over Na2SO4. The solvent was removed in vacuo and the crude
product was puriﬁed by column chromatography, eluting with
ethyl acetate:hexane (25:75 to 75:25) to give acetamides 6aee.
2.3. General procedure for the deacetylation of acetamides 6aee to
produce sulfonamides 7aee
The appropriate acetamide 6aeewas dissolved inmethanol/5M
aqueous NaOH mixture (3:2 v/v) and kept at 85 C. Upon comple-
tion of the reaction, the methanol was removed in vacuo and the
aqueous residue was extracted with DCM (6  25 mL). After drying
over Na2SO4, the organic solvent was removed and the crude
product was puriﬁed by column chromatography on silica, eluting
with ethyl acetate:hexane (50:50 to 60:40) to yield the desired
sulfonamides 7aee.
2.4. General method for preparation of 6-bromo-1H-benz[de]
isoquinoline-1,3(2H)-diones 9
4-Bromo-1,8-naphthalic anhydride 8 (1 equiv.) and the corre-
sponding amine (1 equiv.) were reﬂuxed in ethanol (25 mL) for 2 h.
The solutionwas then allowed to cool to room temperature and the
precipitate which formed was collected by ﬁltration to give the
desired product 9aec.
2.5. General method for the preparation of 6-hydrazino-1H-benz
[de]isoquinoline-1,3(2H)-diones 10
The 2-alkyl-6-bromobenz[de]isoquinolin-1,3(2H)-dione 9aec
(1 equiv.) was reacted with hydrazine hydrate (2 equiv.) in 2-
butanol (25 mL) under reﬂux. After 2 h, additional hydrazine hy-
drate (2 equiv.) was added to the solution and after an additional
4 h, the solution was allowed to cool to room temperature. The
precipitatewhich formedwaswashedwith diethyl ether to give the
desired product 10aec.
2.6. General procedure for the coupling with Boc-b-alanine to give
sulfonamides 11aee and hydrazides 13aec
Boc-b-alanine (8 equiv.) was dissolved in DCM and cooled to
0 C. To this solution, DCCI (4 equiv.) was added and the mixture
was allowed to warm to room temperature and left to stir for 1 h.
This mixture was then ﬁltered into a ﬂask containing the appro-
priate amine 7 or hydrazine 10 (1 equiv.), DIPEA (1.2 equiv.) and
DMAP (0.6 equiv.) in DCM. The resulting solution was then heated
to 50 C and left to stir. Upon completion of the reaction, the
organic layer was washed with saturated NaHCO3 (3  20 mL), 1 M
aqueous HCl (3  20 mL) and water (3  20 mL) then dried over
Na2SO4. The solvent was removed in vacuo and the crude products11aee were puriﬁed by column chromatography on silica, eluting
with ethyl acetate:hexane (20:80 to 50:50).
For the coupling to the hydrazinobenz[de]isoquinolin-1,3(2H)
diones 10aec, after 3 h, additional Boc-b-alanine anhydride
(4 equiv.) was added to the solution. After a further 20 h, the
solvent was removed in vacuo and the residue was puriﬁed via
column chromatography on silica gel. Recrystallization from
ethanol gave the Boc-protected substrates 13aec.2.6.1. tert-Butyl [3-oxo-3-{5-(N-propylsulfamoyl)naphthalen-1-yl}
aminopropyl]carbamate (11a)
Yield of 11a: 20%; White solid; mp 177e179 C; FTIR (neat, v/
cm1): 3291 (NH), 3271 (NH),1684 (C]O),1653 (C]O),1597 (C]C,
aromatic), 1290 (S]O), 1153 (S]O); 1H NMR (400 MHz, CD3OD) d:
0.76 (3H, t, J ¼ 7.4 Hz, CH3-30), 1.36 (2H, sextet, J ¼ 7.2 Hz, CH2-20),
1.46 (9H, s, C(CH3)3), 2.75 (2H, t, J ¼ 6.7 Hz, CH2-a), 2.79 (2H, t,
J¼ 7.0 Hz, CH2-10), 3.48 (2H, t, J¼ 6.7 Hz, CH2-b), 7.62e7.73 (3H, m),
8.24 (1H, d, J ¼ 6.4 Hz), 8.31 (1H, d, J ¼ 8.4 Hz), 8.65 (1H, d,
J ¼ 8.4 Hz); 13C NMR (100 MHz, CD3OD) d: 11.45 (CH3, C-30), 24.0
(CH2, C-20), 28.8 (3 CH3, C(CH3)3), 37.8 (CH2, C-a), 38.1 (CH2, C-b),
45.8 (CH2, C-10), 80.2 (quat., C(CH3)3), 124.6 (CH), 125.4 (CH), 125.5
(CH), 128.5 (CH), 129.5 (CH), 130.3 (quat.), 130.4 (CH), 131.3 (quat.),
135.1 (quat.), 137.5 (quat.), 158.5 (C]O, carbamate CO), 173.6 (C]O,
amide CO); ESI-MS ¼ 436 (M þ H). Anal. Calcd. for C21H29N3O5S
(435): C, 57.91; H, 6.71; N, 9.65. Found: C, 57.99; H, 6.92; N, 9.72%.2.6.2. tert-Butyl [3-oxo-3-{5-(N-butylsulfamoyl)naphthalen-1-yl}
aminopropyl]carbamate (11b)
Yield of 11b: 51%; White solid; mp 175e178 C; FTIR (neat, v/
cm1): 3308 (NH), 3265 (NH),1680 (C]O),1651 (C]O),1620 (C]C,
aromatic), 1290 (S]O), 1150 (S]O); 1H NMR (400 MHz, CD3OD) d:
0.74 (3H, t, J ¼ 7.4 Hz, CH3-40), 1.18 (2H, sextet, J ¼ 7.4 Hz, CH2-30),
1.32 (2H, quintet, J¼ 7.2 Hz, CH2-20), 1.46 (9H, s, C(CH3)3), 2.745 (2H,
t, J ¼ 6.7 Hz, CH2-a), 2.82 (2H, t, J ¼ 6.8 Hz, CH2-10), 3.48 (2H, t,
J ¼ 6.7 Hz, CH2-b), 7.62e7.73 (3H, m), 8.24 (1H, d, J ¼ 6.8 Hz), 8.31
(1H, d, J ¼ 8.4 Hz), 8.64 (1H, d, J ¼ 8.4 Hz); 13C NMR (100 MHz,
CD3OD) d: 13.8 (CH3, C-40), 20.65 (CH2, C-30), 28.8 (3 CH3), 32.7
(CH2, C-20), 37.8 (CH2, C-a), 38.05 (CH2, C-b), 43.6 (CH2, C-10), 80.2
(quat., C(CH3)3), 124.55 (CH), 125.4 (CH), 125.5 (CH), 128.5 (CH),
129.5 (CH),130.3 (quat.),130.4 (CH),131.3 (quat.),135.1 (quat.),137.4
(quat.), 158.5 (C]O, carbamate CO), 173.6 (C]O, amide CO); ESI-
MS ¼ 450 (M þ H). Anal. Calcd. for C22H31N3O5S (449): C, 58.78; H,
6.95; N, 9.35. Found: C, 58.80; H, 7.13; N, 9.40%.2.6.3. tert-Butyl [3-oxo-3-{5-(N-pentylsulfamoyl)naphthalen-1-yl}
aminopropyl]carbamate (11c)
Yield of 11c: 27%; White solid; mp 166e170 C; FTIR (neat, v/
cm1): 3320 (NH), 3269 (NH),1686 (C]O),1653 (C]O),1622 (C]C,
aromatic), 1287 (S]O), 1153 (S]O); 1H NMR (400 MHz, CD3OD) d:
0.74 (3H, t, J ¼ 6.8 Hz, CH3), 1.09e1.14 (4H, m, 2 CH2, 2 H-30 plus
2H-40), 1.29e1.36 (2H, m, CH2-20), 1.46 (9H, s, C(CH3)3), 2.75 (2H, t,
J ¼ 6.8 Hz, CH2-a), 2.82 (2H, t, J ¼ 7.0 Hz, CH2-10), 3.48 (2H, t,
J ¼ 6.6 Hz, CH2-b), 7.62e7.73 (3H, m), 8.24 (1H, d, J ¼ 7.2 Hz), 8.31
(1H, d, J ¼ 8.4 Hz), 8.64 (1H, d, J ¼ 8.4 Hz); 13C NMR (100 MHz,
CD3OD) d: 14.2 (CH3, C-50), 23.1 (2 CH2, C-30 and C-40), 28.8 (3
CH3), 30.3 (CH2, C-20), 37.8 (CH2, C-a), 38.1 (CH2, C-b), 43.9 (CH2, C-
10), 80.2 (quat., C(CH3)3), 124.6 (CH), 125.4 (CH), 125.5 (CH), 128.5
(CH), 129.5 (CH), 130.3 (quat.), 130.4 (CH), 131.3 (quat.), 135.2
(quat.), 137.5 (quat.), 158.5 (C]O, carbamate CO), 173.6 (C]O,
amide CO); ESI-MS ¼ 486 (M þ Na). HRMS Calcd. for
C23H33N3O5SNa: 486.2033. Found: 486.2038.
J.L. Luo et al. / Dyes and Pigments 125 (2016) 15e26182.6.4. tert-Butyl [3-oxo-3-{5-(N-octylsulfamoyl)naphthalen-1-yl}
aminopropyl]carbamate (11d)
Yield of 11d: 37%; White solid; mp 175e177 C; FTIR (neat, v/
cm1): 3275 (NH), 1676 (C]O), 1653 (C]O), 1595 (C]C, aromatic),
1321 (S]O), 1150 (S]O); 1H NMR (400 MHz, CD3OD) d: 0.84 (3H, t,
J ¼ 7.2 Hz, CH3), 1.07e1.15 (8H, m, 4 CH2), 1.20e1.32 (4H, m, 2
CH2), 1.44 (9H, s, C(CH3)3), 2.72 (2H, t, J¼ 6.7 Hz, CH2-a), 2.80 (2H, t,
J¼ 7.0 Hz, CH2-10), 3.46 (2H, t, J¼ 6.7 Hz, CH2-b), 7.59e7.72 (3H, m),
8.22 (1H, d, J ¼ 6.8 Hz), 8.29 (1H, d, J ¼ 8.4 Hz), 8.61 (1H, d,
J ¼ 8.4 Hz); 13C NMR (100 MHz, CD3OD) d: 14.4 (CH3, C-80), 23.7
(CH2), 27.55 (3 CH3), 28.8 (CH2), 30.1 (CH2), 30.2 (CH2), 30.6 (CH2),
32.9 (CH2), 37.8 (CH2, C-200), 36.6 (CH2, C-300), 42.4 (CH2, C-10), 80.23
(quat., C(CH3)3), 124.5 (CH), 125.3 (CH), 125.5 (CH), 128.5 (CH), 129.5
(CH), 130.3 (quat.), 130.4 (CH), 131.2 (quat.), 135.15 (quat.), 137.5
(quat.), 158.5 (C]O, carbamate CO), 173.55 (C]O, amide CO); ESI-
MS ¼ 506 (M þ H); Anal. Calcd. for C26H39N3O5S (505): C, 61.76; H,
7.77; N, 8.31. Found: C, 61.76; H, 8.00; N, 8.34%.
2.6.5. tert-Butyl [3-{2-(1,3-dioxo-2-propyl-2,3-dihydro-1H-benzo
[de]isoquinolin-6-yl)hydrazinyl}-3-oxopropyl]carbamate (13a)
Yield of 13a: 21%; Light yellow solid; mp 193e195 C; FTIR (neat,
v/cm1): 3336 (NH), 3325 (NH), 3279 (NH), 1684 (C]O), 1655
(amide I), 1647 (C]O), 1585 (amide II), 1528 (C]C); 1H NMR
(400 MHz, (CD3)2CO) d: 0.97 (3H, t, J ¼ 7.6 Hz, H-30), 1.45 (9H, s,
C(CH3)3), 1.72 (2H, sextet, J ¼ 7.6 Hz, H-20), 2.66 (2H, t, J ¼ 6.8 Hz,
CH2-a), 3.44 (2H, q, J¼ 6.8 Hz, CH2-b), 4.04e4.08 (2H, m, H-10), 6.08
(1H, broad s, carbamate NH), 7.11 (1H, d, J ¼ 8.4 Hz, H-5), 7.60 (1H,
dd, J ¼ 8.4, 7.6 Hz, H-8), 8.34 (1H, d, J ¼ 8.4 Hz, H-4), 8.43 (1H, dd,
J¼ 7.6,1.2 Hz, H-9), 8.54 (1H, dd, J¼ 8.4,1.2 Hz, H-7), 9.16 (1H, broad
s, amide NH); 13C NMR (100MHz, (CD3)2CO) d: 12.8 (CH3, C-30), 23.1
(CH2, C-20), 29.7 (3 CH3, C(CH3)3), 35.9 (CH2, CH2-a), 38.7 (CH2,
CH2-b), 43.0 (CH2, C-10), 79.8 (quat., C(CH3)3), 107.6 (CH, C-5), 114.6
(quat., C-3a), 121.5 (quat., C-6a), 124.7 (quat., C-9a), 127.0 (CH, C-8),
129.0 (CH, C-7), 131.1 (quat., C-3b), 132.3 (CH, C-9), 134.9 (CH, C-4),
152.1 (quat., C-6), 157.6 (C]O, carbamate CO), 165.1 (C]O, C-3),
165.6 (C]O, C-1), 172.9 (C]O, amide CO); ESI-MS ¼ 442 (M þ H).
2.6.6. tert-Butyl [3-{2-(1,3-dioxo-2-pentyl-2,3-dihydro-1H-benzo
[de]isoquinolin-6-yl)hydrazinyl}-3-oxopropyl]carbamate (13b)
Yield of 13b: 19%; Yellow-brown solid; mp 150e154 C; FTIR
(neat, v/cm1): 3357 (NH), 3312 (NH), 3221 (NH), 1688 (C]O), 1674
(amide I), 1639 (C]O), 1614 (amide II), 1587 (C]C), 1519 (C]C); 1H
NMR (400 MHz, (CD3)2CO) d: 0.93 (3H, t, J¼ 7.2 Hz, H-50), 1.38e1.41
(4H, m, H-30, H-40), 1.46 (9H, s, C(CH3)3), 1.72 (2H, quintet, J¼ 7.6 Hz,
H-20), 2.70 (2H, t, J ¼ 6.4 Hz, CH2-a), 3.47 (2H, q, J ¼ 6.4 Hz, CH2-b),
4.07 (2H, t, J ¼ 7.6 Hz, H-10), 6.13 (1H, broad s, carbamate NH), 7.06
(1H, d, J ¼ 8.0 Hz, H-5), 7.39 (1H, dd, J ¼ 8.4, 7.6 Hz, H-8), 8.26e8.29
(2H, m, H-4, H-9), 8.38 (1H, dd, J¼ 8.4, 0.8 Hz, H-7), 9.08 (1H, broad
s, NH), 9.49 (1H, broad s, NH); 13C NMR (100 MHz, (CD3)2CO) d: 15.3
(CH3, C-50), 24.1 (CH2, C-40), 29.5 (CH2, C-20), 29.7 (3 CH3, C(CH3)3),
31.1 (CH2, C-30), 36.0 (CH2, CH2-a), 38.7 (CH2, CH2-b), 41.4 (CH2, C-
10), 80.0 (quat., C(CH3)3), 107.3 (CH, C-5), 114.6 (quat., C-3a), 121.2
(quat., C-6a), 124.4 (quat., C-9a), 126.8 (CH, C-8), 128.8 (CH, C-7),
130.8 (quat., C-3b), 131.9 (CH, C-9), 134.8 (CH, C-4), 151.9 (quat., C-
6), 157.7 (C]O, carbamate CO), 165.0 (C]O, C-3), 165.5 (C]O, C-1),
173.4 (C]O, amide CO); ESI-MS ¼ 469 (M þ H).
2.6.7. tert-Butyl [3-{2-(1,3-dioxo-2-benzyl-2,3-dihydro-1H-benzo
[de]isoquinolin-6-yl)hydrazinyl}-3-oxopropyl]carbamate (13c)
Yield of 13c: 34%; Yellow solid; mp 175e177 C; FTIR (neat, v/
cm1): 3387 (NH), 3318 (NH), 3298 (NH), 1684 (C]O), 1653 (amide
I), 1647 (C]O), 1638 (amide II), 1578 (C]C), 1541 (C]C), 1521 (C]
C), 1508 (C]C); 1H NMR (400 MHz, (CD3)2CO) d: 1.45 (9H, s,
C(CH3)3), 2.67 (2H, t, J ¼ 6.8 Hz, CH2-a), 3.44 (2H, t, J ¼ 6.8 Hz, CH2-
b), 4.56 (1H, s, carbamate NH), 5.32 (2H, s, CH2), 7.11 (1H, d,J ¼ 8.4 Hz, H-5), 7.19e7.23 (1H, m, H-40), 7.27e7.31 (2H, m, H-30, 50),
7.44e7.47 (2H, m, H-20, 60), 7.58 (1H, dd, J ¼ 8.4, 7.2 Hz, H-8), 8.35
(1H, d, J ¼ 8.4 Hz, H-4), 8.43 (1H, dd, J ¼ 7.2, 0.8 Hz, H-9), 8.54 (1H,
dd, J ¼ 8.4, 0.8 Hz, H-7), 8.89 (1H, broad s, amide NH), 9.54 (1H,
broad s, amide NH); 13C NMR (100 MHz, (CD3)2CO) d: 29.7 (3 CH3,
C(CH3)3), 35.9 (CH2, CH2-a), 38.5 (CH2, CH2-b), 44.7 (CH2), 79.9
(quat., C(CH3)3), 107.7 (CH, C-5), 114.4 (quat., C-3a), 121.4 (quat., C-
6a), 124.5 (quat., C-9a), 127.0 (CH, C-8), 128.8 (CH, C-40), 129.3 (CH,
C-7),130.01 (2 CH, C-20, 60), 130.04 (2 CH, C-30, 50), 131.1 (quat., C-
3b), 132.6 (CH, C-9), 135.2 (CH, C-4), 140.2 (quat., C-10), 152.3 (quat.,
C-6), 165.1 (C]O, C-3), 165.7 (C]O, C-1), 174.1 (C]O, amide CO);
ESI-MS ¼ 511 (M þ Na).
2.7. General procedure for the removal of Boc protecting group to
give salts 12aee and 14aec
Boc-protected substrates 11aee and 13aec were dissolved in
DCM (5 mL) and the solution cooled to 0 C in an ice bath. DCM/TFA
(5 drops of 1:1 mixture) was added to this solution which was
allowed to stir for 2 h while warming to room temperature. The
solvent and excess TFA were removed in vacuo after the addition of
methanol (50 mL). The residue was then triturated with diethyl
ether and the solid formed was ﬁltered to give the products 12aee,
or the reaction vessel was cooled at 80 C overnight to give the
ﬁnal substrate 14aec as a TFA salt.
2.7.1. 3-Amino-N-{5-(N0-propylsulfamoyl)naphthalen-1-yl}
propanamide triﬂuoroacetate salt (12a)
Yield of 12a: 87%; Off-white solid; mp 155e158 C; FTIR (neat, v/
cm1): 3265 (NH), 3163 (NH), 1668 (C]O, amide), 1597 (C]C, ar-
omatic), 1305 (S]O), 1134 (S]O); 1H NMR (400 MHz, D2O) d: 0.68
(3H, t, J ¼ 7.4 Hz, CH3), 1.32 (2H, sextet, J ¼ 7.2 Hz, CH2-20), 2.86 (2H,
t, J ¼ 6.8 Hz, CH2-10), 3.09 (2H, t, J ¼ 6.6 Hz, CH2-a), 3.41 (2H, t,
J ¼ 6.0 Hz, CH2-b), 7.65e7.71 (2H, m), 7.78 (1H, t, J ¼ 8.2 Hz),
8.26e8.30 (2H, m), 8.58 (1H, d, J¼ 8.8 Hz); 13C NMR (100MHz, D2O)
d: 10.2 (CH3-30), 22.0 (CH2, C-20), 31.9 (CH2, C-a), 35.4 (CH2, C-b),
44.45 (CH2, C-10), 123.4 (CH), 125.0 (CH), 125.4 (CH), 128.1 (CH),
128.2 (quat.), 128.8 (CH), 129.9 (CH), 130.0 (quat.), 132.5 (quat.),
133.8 (quat.), 172.3 (C]O, amide CO); ESI-MS¼ 336 (MþH); HRMS
Calcd. for C16H22N3O3S: 336.1376. Found: 336.1379.
2.7.2. 3-Amino-N-{5-(N0-butylsulfamoyl)naphthalen-1-yl}
propanamide triﬂuoroacetate salt (12b)
Yield of 12b: 53%; Off-white solid; mp 152e155 C; FTIR (neat, v/
cm1): 3267 (NH), 1670 (C]O, amide), 1597 (C]C, aromatic), 1319
(S]O), 1134 (S]O); 1H NMR (400 MHz, D2O) d: 0.60 (3H, t,
J ¼ 7.4 Hz, CH3), 1.06 (2H, sextet, J ¼ 7.4 Hz, CH2-30), 1.235 (2H,
quintet, J ¼ 7.2 Hz, CH2-20), 2.88 (2H, t, J ¼ 6.8 Hz, CH2-10), 3.08 (2H,
t, J ¼ 6.5 Hz, CH2-a), 3.40 (2H, t, J ¼ 6.5 Hz, CH2-b), 7.63e7.68 (2H,
m), 7.76 (1H, t, J ¼ 8.2 Hz), 8.24e8.27 (2H, m), 8.56 (1H, d,
J ¼ 8.8 Hz); 13C NMR (100 MHz, D2O) d: 12.4 (CH3), 18.8 (CH2, C-30),
30.4 (CH2, C-20), 31.9 (CH2, C-a), 35.4 (CH2, C-b), 42.2 (CH2, C-10),
123.3 (CH), 125.0 (CH), 125.3 (CH), 128.1 (CH), 128.2 (quat.), 128.8
(CH), 130.0 (CH and quat.), 132.5 (quat.), 133.7 (quat.), 172.3 (C]O,
amide CO); ESI-MS ¼ 350 (M þ H); HRMS Calcd. for C17H24N3O3S:
350.1533. Found: 350.1536.
2.7.3. 3-Amino-N-{5-(N0-pentylsulfamoyl)naphthalen-1-yl}
propanamide triﬂuoroacetate salt (12c)
Yield of 12c: 95%; White solid; mp 141e144 C; FTIR (neat, v/
cm1): 3294 (NH), 3265 (NH), 1670 (C]O, amide), 1624 (C]C, ar-
omatic), 1290 (S]O), 1125 (S]O); 1H NMR (400 MHz, D2O) d: 0.53
(3H, t, J ¼ 6.4 Hz, CH3), 0.84e0.97 (4H, m, 2 CH2, CH2-30,40), 1.19
(2H, t, J ¼ 6.6 Hz, CH2-20), 2.86 (2H, t, J ¼ 6.6 Hz, CH2-10), 3.07 (2H, t,
J ¼ 6.6 Hz, CH2-a), 3.40 (2H, t, J ¼ 6.4 Hz, CH2-b), 7.60e7.64 (2H, m),
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13C NMR (100 MHz, D2O) d: 12.8 (CH3), 21.05 (CH2, C-40), 27.6 (CH2,
C-30), 27.85 (CH2, C-20), 32.0 (CH2, C-a), 35.4 (CH2, C-b), 42.4 (CH2, C-
10), 123.3 (CH), 124.95 (CH), 125.2 (CH), 128.0 (CH), 128.15 (quat.),
128.7 (CH), 129.8 (quat.), 129.9 (CH), 132.5 (quat.), 133.8 (quat.),
172.2 (C]O, amide CO); ESI-MS ¼ 364 (M þ H); HRMS Calcd. for
C18H26N3O3S: 364.1689. Found: 364.1692.
2.7.4. 3-Amino-N-{5-(N0-octylsulfamoyl)naphthalen-1-yl}
propanamide triﬂuoroacetate salt (12d)
Yield of 12d: 58%; Off-white solid; 175e177 C; FTIR (neat, v/
cm1): 3250 (NH), 1668 (C]O, amide), 1599 (C]C, aromatic), 1314
(S]O), 1132 (S]O); 1H NMR (400 MHz, D2O) d: 0.67 (3H, t,
J ¼ 7.2 Hz, CH3), 0.80e1.11 (10H, m, 5 CH2), 1.20 (2H, br s, CH2-20),
2.70 (2H, br s, CH2-10), 2.91 (2H, t, J ¼ 6.4 Hz, CH2-b), 3.24 (2H, t,
J ¼ 6.4 Hz, CH2-a), 7.33e7.44 (3H, m), 7.94 (1H, d, J ¼ 6.8 Hz), 8.09
(1H, d, J¼ 8.4 Hz), 8.40 (1H, d, J¼ 8.0 Hz); 13C NMR (100 MHz, D2O)
d: 13.5 (CH3), 22.2 (CH2), 26.0 (CH2), 28.5 (CH2), 28.7 (CH2), 29.1
(CH2-20), 31.3 (CH2), 32.0 (CH2-b), 35.3 (CH2-a), 42.6 (CH2-10), 123.0
(CH), 124.5 (2 CH), 127.75 (CH), 128.1 (quat.), 128.5 (CH), 129.0
(CH), 129.45 (quat.), 132.5 (quat.), 134.4 (quat.), 171.6 (C]O, amide
CO); ESI-MS ¼ 406 (M þ H); HRMS Calcd. for C21H32N3O3S:
406.2159. Found: 406.2161.
2.7.5. 3-Amino-N-{5-(N0-benzylsulfamoyl)naphthalen-1-yl}
propanamide triﬂuoroacetate salt (12e)
The reaction of 5-amino-N-propylnaphthalene-1-sulfonamide
7e (0.55 g, 1.76 mmol) with Boc-b-alanine (2.665 g, 14.08 mmol),
DCCI (1.451 g, 7.04 mmol), DIPEA (0.273 g, 2.11 mmol) and DMAP
(0.129 g, 1.06 mmol), as described above, gave a white solid 11e
(1.038 g) which was used without further puriﬁcation.
Carbamate 11e (0.9 g) was deprotected using the general
method to give a beige solid which was taken up in water, then the
pH was adjusted to 14 with 1 M aq. NaOH (aq). The aqueous layer
was then extracted with ethyl acetate (5  30 mL), and the com-
bined organic layers were dried over Na2SO4 and reduced in vacuo
to give the free amine of amide 12e (0.49 g) as a white solid. This
free base was then converted into the triﬂuoroacetate salt with TFA
(0.15 mL) in DCM (10 mL) at 0 C. The white solid product 12e was
obtained after trituration with diethyl ether (0.438 g, 50% over 2
steps); mp 100e102 C; FTIR (neat, v/cm1): 3273 (NH),1655 (C]O,
amide), 1599 (C]C, aromatic), 1311 (S]O), 1138 (S]O); 1H NMR
(400 MHz, D2O) d: 3.06 (2H, t, J ¼ 6.6 Hz, CH2-a), 3.395 (2H, t,
J ¼ 6.6 Hz, CH2-b), 4.08 (2H, s, NCH2), 6.83e6.98 (5H, m, CHPh),
7.49e7.58 (2H, m), 7.67 (1H, t, J ¼ 8.0 Hz), 8.06e8.12 (2H, m), 8.41
(1H, d, J ¼ 8.8 Hz); 13C NMR (100 MHz, D2O) d: 31.9 (CH2, CH2-a),
35.4 (CH2, CH2-b), 46.2 (NCH2), 123.1 (CH), 124.9 (CH), 125.0 (CH),
127.2 (C-40), 127.4 (C-20 and C-60), 127.8 (C-30 and C-50), 127.9 (CH),
128.0 (quat.), 128.7 (CH), 129.6 (quat.), 130.2 (CH), 132.3 (quat.),
133.8 (quat.), 135.5 (C-10), 172.1 (C]O, amide CO); ESI-MS
(ESI) ¼ 384 (M þ H); HRMS Calcd. for C20H22N3O3S: 384.1376.
Found: 384.1379.
2.7.6. 3-Amino-N0-(2-propyl-1,3-dioxo-2,3-dihydro-1H-benz[de]
isoquinolin-6-yl)propanehydrazide triﬂuoroacetate (14a)
Yield of 14a: 89%; Light orange crystals; mp 134e136 C; FTIR
(nujol, v/cm1): 3482 (NH), 3252 (NH), 1687 (C]O), 1672 (amide I),
1646 (C]O), 1614 (amide II), 1582 (C]C), 1533 (C]C); 1H NMR
(400 MHz, CD3OD) d: 0.99 (3H, t, J ¼ 7.6 Hz, C-30), 1.73 (2H, sextet,
J ¼ 7.6 Hz, C-20), 2.86 (2H, t, J ¼ 6.8 Hz, CH2-a), 3.31e3.34 (2H, m,
CH2-b), 4.07e4.11 (2H, m, H-10), 7.03 (1H, d, J ¼ 8.4 Hz, H-5),
7.70e7.74 (1H, m, H-8), 8.40 (1H, d, J ¼ 8.4 Hz, H-4), 8.51 (1H, d,
J ¼ 8.8 Hz, H-9), 8.55 (1H, d, J ¼ 7.6 Hz, H-7); 13C NMR (100 MHz,
CD3OD) d: 11.8 (CH3, C-30), 22.5 (CH2, C-20), 31.3 (CH2, CH2-a), 36.8
(CH2, CH2-b), 42.7 (CH2, C-10), 106.5 (CH, C-5), 113.4 (quat., C-3a),120.9 (quat., C-6a), 123.7 (quat., C-9a), 126.4 (CH, C-8), 129.1 (CH, C-
7), 130.7 (quat., C-3b), 132.4 (CH, C-9), 135.0 (CH, C-4), 151.7 (quat.,
C-6), 165.7 (C]O, C-3), 166.0 (C]O, C-1), 172.3 (C]O); ESI-
MS ¼ 341 (M þ H); HRMS Calcd. for C18H21N4O3: 341.1608. Found:
341.1605.2.7.7. 3-Amino-N0-(2-pentyl-1,3-dioxo-2,3-dihydro-1H-benz[de]
isoquinolin-6-yl)propanehydrazide triﬂuoroacetate (14b)
Yield of 14b: 94%; Bright yellow solid; mp 122e127 C; FTIR
(nujol, v/cm1): 3392 (NH), 3336 (NH), 3197 (NH), 1707 (C]O),
1674 (amide I), 1638 (C]O), 1615 (amide II), 1585 (C]C), 1532 (C]
C); 1H NMR (400 MHz, CD3OD) d: 0.92 (3H, t, J ¼ 6.8 Hz, H-50),
1.35e1.40 (4H, m, H-30, H-40), 1.68 (2H, quintet, J ¼ 7.6 Hz, H-20),
2.85 (2H, t, J ¼ 6.4 Hz, CH2-a), 3.29 (2H, m, CH2-b), 4.08 (2H, t,
J ¼ 7.6 Hz, H-10), 7.00 (1H, d, J ¼ 8.4 Hz, H-5), 7.66 (1H, dd, J ¼ 8.4,
7.2 Hz, H-8), 8.36 (1H, d, J¼ 8.4 Hz, H-4), 8.46 (1H, dd, J¼ 8.4, 0.8 Hz,
H-9), 8.49 (1H, dd, J¼ 7.2, 0.8 Hz, H-7); 13C NMR (100 MHz, CD3OD)
d: 14.4 (CH3, C-50), 23.5 (CH2, C-40), 28.9 (CH2, C-20), 30.4 (CH2, C-30),
31.2 (CH2, CH2-a), 36.8 (CH2, CH2-b), 41.2 (CH2, C-10), 106.5 (CH, C-
5), 113.4 (quat., C-3a), 120.9 (quat., C-6a), 123.7 (quat., C-9a), 126.4
(CH, C-8), 129.1 (CH, C-7), 130.7 (quat., C-3b), 132.4 (CH, C-9), 134.9
(CH, C-4), 151.7 (quat., C-6), 165.6 (C]O, C-3), 166.0 (C]O, C-1),
172.3 (C]O); ESI-MS ¼ 369 (M þ H); HRMS Calcd. for C20H25N4O3:
369.1921. Found: 369.1918.2.7.8. 3-Amino-N0-(2-benzyl-1,3-dioxo-2,3-dihydro-1H-benz[de]
isoquinolin-6-yl)propanehydrazide triﬂuoroacetate (14c)
Yield of 14c: 96%; Orange solid; mp 131e133 C; FTIR (nujol, v/
cm1): 3462 (NH), 3219 (NH), 1701 (C]O), 1684 (amide I), 1640
(C]O), 1614 (amide II), 1577 (C]C); 1H NMR (400 MHz, CD3OD)
d: 2.86 (2H, t, J ¼ 6.8 Hz, CH2-a), 3.30e3.35 (2H, m, CH2-b), 5.32
(2H, s, CH2), 7.03 (1H, d, J ¼ 8.4 Hz, H-5), 7.19e7.23 (1H, m, H-40),
7.26e7.30 (2H, m, H-30, 50), 7.40e7.42 (2H, m, H-20, 60), 7.72 (1H,
dd, J ¼ 8.4, 7.6 Hz, H-8), 8.41 (1H, d, J ¼ 8.4 Hz, H-4), 8.52 (1H, dd,
J ¼ 8.4, 0.8 Hz, H-9), 8.56 (1H, dd, J ¼ 7.6, 0.8 Hz, H-7); 13C NMR
(100 MHz, CD3OD) d: 31.2 (CH2, CH2-a), 36.8 (CH2, CH2-b), 44.3
(CH2), 106.6 (CH, C-5), 113.2 (quat., C-3a), 120.9 (quat., C-6a),
123.6 (quat., C-9a), 126.5 (CH, C-8), 128.3 (CH, C-40), 129.2 (2 CH,
C-20, 60), 129.3 (CH, C-7), 129.4 (2 CH, C-30, 50), 130.8 (quat., C-
3b), 132.6 (CH, C-9), 135.2 (CH, C-4), 139.1 (quat., C-10), 151.8
(quat., C-6), 165.6 (C]O, C-3), 166.0 (C]O, C-1), 172.3 (C]O);
ESI-MS ¼ 389 (M þ H); HRMS Calcd. for C22H21N4O3: 389.1608.
Found: 389.1606.2.8. General method for the coupling of hydrazines 10 to aryl
aldehydes
The hydrazines 10aec (1 equiv.) and aryl aldehydes (1.1 equiv.)
were dissolved in ethanol (25 mL) and stirred at 80 C for 2 h with
ﬁve drops of glacial acetic acid as a catalyst. The solution was then
allowed to cool and the formed precipitate was taken to obtain ﬁnal
compounds 17e21.2.9. Fluorescence properties
In vitro ﬂuorescent assessment of ﬂuorophores (7aee:
5  104 M; 10aec: 1  104 M), substrates (12aee: 5  104 M;
14aec: 1  104 M), and hydrazones 17e21 (17,18: 1  105 M;
19e21: 1  104 M) in ethanol was carried out on a Shimadzu RF-
5301PC spectrophotometer using identical scan parameters, uti-
lizing a 5 mm slit width, if not stated otherwise.
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2.10.1. Preparation of culture media containing substrates 12aee
and 14aec
Columbia agar was prepared as follows; 41 g of Columbia agar
(Oxoid Basingstoke, UK) was added to deionized water and the
volume was made up to 1 L. The medium was sterilized by auto-
claving at 116 C for 20 min and left to cool at 50 C. 2 mg of each
substrate 12aee and 14aec to be tested was initially dissolved in
100 mL of N-methylpyrrolidone and this was added to Columbia
agar (made up to 20 mL), then poured into sterile Petri dishes to
give a ﬁnal concentration of 100 mg/L for the substrates. Columbia
agar incorporating an equivalent concentration of N-methyl-
pyrrolidone was used as a growth control.
2.10.2. Microbial suspension preparation
Microbial reference strains were obtained from either the Na-
tional Collection of Type Cultures (NCTC) or the National Collection
of Pathogenic Fungi (NCPF) which are both located at the Central
Public Health England Laboratory, Colindale, UK or the American
Type Culture Collection (ATCC), Manassas, USA. The 20 test mi-
croorganisms were maintained on Columbia agar.
2.10.3. Multipoint inoculation
Colonies of each microbial strain were harvested using a loop
from overnight cultures on Columbia agar. These were suspended
in sterile deionized water to a suspension equivalent to 0.5
McFarland units using a densitometer. 100 mL of this suspension
was pipetted into the corresponding wells of a multipoint inocu-
lation device. Each set of plates received 1 mL of bacterial suspen-
sion, giving 1.5  105 organisms per spot on each inoculation.
Twenty strains were inoculated per plate and the plates were
incubated for 18 h in air at 37 C.
2.10.4. Activity determination
After incubation, the activity of the microorganisms with the
test substrates was determined by observing the plates under UV
irradiation at 365 nm and comparing with the substrate-free
control.
3. Results and discussion
3.1. Preparation of 5-amino-1-naphthalenesulfonamides (ANS)
Starting from 5-amino-1-naphthalenesulfonic acid 3, the amino
group was protected via N-acetylation as described by Xu et al. [18]
to give imide 4 in excellent yield, Scheme 1. In order to synthesize
the ﬂuorophores 7aee, the sulfonic acid group was converted to a
sulfonyl chloride 5 [19] which was subsequently reacted with a
series of amines, to form the acetamides 6aee in moderate yieldsScheme 1. Synthesis of 5-amino-1-naphthalenesulfonamides 7aee. Reagents and conditions
rt, 3 h, 90%; (iv) RNH2, Et3N, DCM, rt, 8 h; (v) 5 M NaOH (aq.), 85 C, 20 h.via a nucleophilic substitution. Removal of theN-acetyl group of the
acetamides 6aee gave the sulfonamide ﬂuorophores 7aee.
3.2. Preparation of 6-hydrazinobenz[de]isoquinoline-1,3-diones (6-
HBI) 10aec
Synthesis of the desired 6-hydrazinobenz[de]isoquinoline-1,3-
diones (6-HBI) 10aec was achieved in two steps; a range of 6-
bromobenz[de]isoquinoline-1,3-diones 9aec were prepared, in
high yields, Scheme 2, from4-bromo-1,8-naphthalic anhydride 8 by
using an adaptation of the method of Wang et al. [20]. The subse-
quent substitution of the bromine was achieved by reaction with
hydrazine hydrate in ethanol, under reﬂux, to give the ﬂuorophores
10aec [14], Scheme 3. This step was optimized via the addition of
hydrazine in portions over a period of time, resulting in an
approximately 20% increase in reaction yield, and the products
were then isolated by recrystallization of the crude residues from2-
butanol.
3.3. Amide 12 and hydrazide 14 formation
Each of the ﬂuorophores 7aee and 10aecwere initially coupled
to Boc-b-Ala-OH using the activated pentaﬂuorophenyl ester, as
described by Nakatani et al. [21]. However, the presumed instability
of the ester resulted in low yields of the desired products 11aee and
13aec. Alternatively, the coupling was carried out by the formation
of the symmetrical anhydride of Boc-b-Ala-OH (using DCCI as a
dehydrating agent), Scheme 3, which was then added to a mixture
of 7aee or 10aec and DMAP, DIPEA in DCM [22]. The subsequent
deprotection of 11aee and 13aec in TFA/DCM (1:6 v/v) gave the
triﬂuoroacetate salts 12aee and 14aec, in moderate to good yields,
for microbiological evaluation.
3.4. Secondary reaction of 6-hydrazinobenz[de]isoquinoline-1,3-
diones (6-HBI) 10aec with aldehydes
A range of aryl aldehydes 15 and 16 and the appropriate 6-
hydrazinobenz[de]isoquinoline-1,3-dione 10aec were stirred un-
der reﬂux in ethanol for 2 h, in the presence of catalytic amounts of
glacial acetic acid, Scheme 4. The isolation of products 17e21, as a
range of orange to dark purple solids, was achieved in good yields
by the ﬁltration of the precipitate which formed upon cooling.
3.5. Fluorescence properties
As discussed earlier, the ﬂuorescence properties of a substrate
compared to those of a ﬂuorophore are sufﬁcient for their appli-
cation in bacterial diagnostics when a signiﬁcant change in ﬂuo-
rescence intensity or a signiﬁcant shift in the emission wavelength
is observed.: (i) 1 M NaOH (aq.), rt, 30 min, 99%; (ii) Ac2O, 130 C, 16 h, 80%; (iii) SOCl2, DMF, 0 C to
Scheme 2. Synthesis of 6-hydrazinobenz[de]isoquinoline-1,3-diones 10aec. Reagents and conditions: (i) RNH2, EtOH, reﬂux, 20e25 h; ii) NH2NH2$H2O, EtOH, reﬂux, 24 h.
Scheme 3. Amide and hydrazide bond formation and deprotection to give ﬂuorogenic substrates 12aee and 14aec. Reagents and conditions: (i) Boc-b-Ala-OH, DCC, DIPEA, DMAP,
DCM, rt or 50 C, 24 h; (ii) TFA/DCM (1:6), 0 C to rt, 2 h.
Scheme 4. Secondary reaction of substituted aryl aldehydes 15 and 16 with 6-hydrazinobenz[de]isoquinoline-1,3-diones 10aec to form ﬂuorescent hydrazones 17e21. Reagents
and conditions: (i) EtOH, reﬂux, 2 h.
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Fig. 3. Emission spectra for substrate 12c (slit width ¼ 3 mm) (dashed blue line) and
ﬂuorophore 7c (slit width ¼ 5 mm) (solid green line) (both 5  104 M in EtOH)
(intensities are shown in arbitrary units).
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in vitro ﬂuorescent assessment of ﬂuorophores 7aee, 10aec, sub-
strates 12aee, 14aec, and hydrazones 17e21 was carried out in
ethanol.
3.5.1. Fluorescence properties of ANS derivatives
The ANS substrates 12aee displayed excitation maxima of
339 nm across the ﬁve compounds while the emission maxima
ranged from 421 to 426 nm, resulting in Stokes shifts of 82e87 nm,
Table 1. Changes in the N-substituent had little or no effect on the
ﬂuorescence properties, as shown by the identical excitation and
narrow range of emission maxima. The ANS ﬂuorophores 7aee,
however, exhibited excitation and emission maxima of
391e408 nm and 514e519 nm, respectively, with Stokes shifts of
111e125 nm as shown in Table 1. Similarly to the substrates, the
alkyl chain length of the N-substituents had a negligible effect on
the observed ﬂuorescence properties, while the benzyl substituent
had only a slight effect. When comparing the emission maxima
between the substrates 12 and ﬂuorophores 7, e.g. Fig. 3, an average
bathochromic shift of 93 nm was observed, suggesting that these
would be ideal ﬂuorogenic substrates for the detection of bacteria.
3.5.2. Fluorescence properties of 6-HBI derivatives
Evaluation of the ﬂuorescence properties of all synthesized
hydrazines 10aec, Boc-protected hydrazides 13aec, intended
enzyme substrates 14aec and hydrazones 17e21, was performed at
a concentration of 1  104 M in ethanol. The hydrazones 17aec
and 18aec displayed signiﬁcantly enhanced ﬂuorescence, sur-
passing the detection limit of the spectrophotometer, so that the
ﬂuorescence of these compounds was studied at a concentration of
1  105 M.
Similarly to the ANS derivatives, differences in the N-sub-
stituents on the 6-HBI core resulted in relatively little effect on the
ﬂuorescence properties observed (Figs. 4 and 5, Table 2) with the
exception of 10c, where a markedly increased emission intensity
was observed compared to derivatives 10a,b. Interestingly, this
increase in ﬂuorescence disappeared once 10c was coupled to Boc-
b-alanine (13,14) or when reacted with an aldehyde to form
hydrazones 17e21. This decrease in intensity is presumably due, in
part, to the engagement of the lone pair of the 4-hydrazinyl moiety
in further resonance structures of 13e14 and 17e21.
The 6-HBI substrates 14aec exhibited excitation maxima of
442e444 nm, with corresponding emission maxima of
509e511 nm, with a Stokes shift of 67 nm. In comparison, the ﬂu-
orophores 10aec displayed excitation maxima of 465e476 nm and
emission maxima of 534e536 nm. This would correspond to a
slight bathochromic shift (23e27 nm) if the substrates 14aecwere
enzymatically cleaved to give the ﬂuorophores 10aec. Unfortu-
nately, such a small shift would be likely produce little or no effect
on the observed colour of the ﬂuorescence and a secondaryTable 1
Excitation maxima, emission maxima and corresponding Stokes shifts for substrates
12aee (slit width ¼ 3 mm) and ﬂuorophores 7aee (slit width ¼ 5 mm).
Compound lex (nm) lem (nm) Stokes shift (Dn, nm)
12 a 339 422 83
b 339 423 84
c 339 422 83
d 339 421 82
e 339 426 87
7 a 391 516 125
b 394 515 121
c 392 517 125
d 395 514 119
e 408 519 111reaction would need to be utilized to further enhance the differ-
entiation between the ﬂuorophore and the substrate.
Reaction of the ﬂuorophores 10aec with aryl aldehydes 15 and
16 resulted in the formation of hydrazones 17e21 with greatly
increased ﬂuorescence intensities (2-fold to>10-fold) in most cases
(except for 20aec), Fig. 5 and Table 3, and a bathochromic shift
(compounds 19e21) of the maximum emission wavelength. The
extent of this bathochromic effect on the emission maximum can
be related to the electron withdrawing/donating characteristics of
the aryl aldehydes used (4-N(CH3)2 > 4-OCH3 > benzaldehyde > 4-
Cl). Electron-donating substituents 19,20 displayed greater bath-
ochromic effects (D 23e52 nm), while electron-withdrawing sub-
stituents 17,16 had insigniﬁcant effects on the emission
wavelengths. Further extension of the conjugation, with an addi-
tional double bond, as seen in compounds 21aec, resulted in a
similar bathochromic effect to that of compounds 19aec, contain-
ing a weakly electron-donating group.
Hydrazones 20aec, containing a dimethylamino group, pro-
duced the greatest recorded bathochromic shift, but were distin-
guished by relatively weak ﬂuorescence at the studied
concentrations (104 M), presumably due to the facilitated rota-
tional decay to the ground state offered by the dimethylamino
group disrupting the electronic properties, and resulting in
quenching of the ﬂuorescence [23]. The greatest intensiﬁcation of
ﬂuorescence emission was observed for the benzaldehyde (17aec)
and 4-chlorobenzaldehyde (18aec) derived hydrazones.
3.6. Microbiological testing of b-alanylaminonaphthalenesulfona-
mides (ANS) 12 and 6-(b-alanyl)hydrazinobenz[de]isoquinoline-
1,3-diones 14
The substrates 12aee and 14aec were incorporated into a
commercially available Columbia medium and subjected to
microbiological evaluation against a range of clinically relevant
microorganisms. All of the substrates were tested on ten Gram
negative and eight Gram positive bacteria and two yeasts.
When observed under long-wave UV light, the colonies of
strains hydrolyzing the substrates should display a signiﬁcant
change in ﬂuorescence in comparison to those which do not hy-
drolyze the substrate and the dark background of the medium,
Figs. 7 and 8. However, none of the visualized plates exhibited the
ﬂuorescence associated with the expected released of ﬂuorophores
7aee, Fig. 8. Upon further investigation, it was discovered that the
medium used for bacterial growth quenches the ﬂuorescence of the
released ﬂuorophores 7aee, Fig. 6.
Fig. 4. a) Emission spectra (at lex ¼ 443 nm) of substrate 14a in EtOH (1  104 M)
(black line), water (blue line), brine (red line), MuellereHinton broth (green line)
(100 mg/L in water, brine and MuellereHinton broth); b) Emission spectra (at
lex ¼ 465 nm) of ﬂuorophore 10a in EtOH (1  104 M) (black line), water (blue line),
brine (red line), MuellereHinton broth (green line) (100 mg/L in water, brine and
MuellereHinton broth). The dashed green line in both ﬁgures represents the spectrum
of MuellereHinton broth alone. All intensities are shown in arbitrary units.
Fig. 5. Emission spectra of ﬂuorophore 10a (dashed blue line) and hydrazones 17a
(solid red line), 18a (solid green line), 19a (solid purple line), 20a (solid black line), and
21a (solid orange line on baseline) (17a, 18a: 1  105 M in EtOH, 10a, 19ae21a:
1  104 M in EtOH) (slit width ¼ 5 mm) (intensities are shown in arbitrary units).
Fig. 6. a) Emission spectra (at lex ¼ 339 nm) of substrate 12b in EtOH (5  104 M)
(black line), water (blue line), brine (red line), MuellereHinton broth (green line)
(100 mg/L in water, brine and MuellereHinton broth); b) Emission spectra (at
lex ¼ 394 nm) of ﬂuorophore 7b in EtOH (5  104 M) (black line), water (blue line),
brine (red line), MuellereHinton broth (green line) (100 mg/L in water, brine and
MuellereHinton broth) The dashed green line in both ﬁgures represents the spectrum
of MuellereHinton broth alone. All intensities are shown in arbitrary units; c)
Observed ﬂuorescence (lex ¼ 365 nm) of sulfonamide 7b in MuellereHinton broth
(left) and ethanol (right).
Table 2
Excitation wavelengths, emission wavelengths and the corresponding Stokes shifts
of substrates 14aec and ﬂuorophores 10aec.
Compound lex lem Stokes shift (Dn, nm)
14 a 443 510 67
b 444 511 67
c 442 509 67
10 a 465 535 70
b 476 534 58
c 472 536 64
J.L. Luo et al. / Dyes and Pigments 125 (2016) 15e26 23Furthermore, while substrates 12aec and 12e did not inhibit
bacterial growth, in the presence of substrate 12d only Providencia
rettgeri, Serratia marcescens and Burkholderia cepacia were able to
grow. The greater toxicity of 12d compared to the other substrates is
presumably due to its longer octyl chain disrupting the integrity of
the bacterial cytoplasmicmembrane and this is supported by the fact
Table 3
Excitation wavelengths, emission wavelengths and the corresponding Stokes shifts
of hydrazones 17e21.
Compound lex lem Stokes shift (Dn, nm)
17 a 467 538 71
b 469 538 69
c 472 538 66
18 a 467 536 69
b 467 536 69
c 471 537 66
19 a 517 559 42
b 519 557 38
c 517 559 42
20 a 433 587 154
b 424 554 130
c 433 579 146
21 a 516 553 37
b 516 555 39
c 519 554 35
J.L. Luo et al. / Dyes and Pigments 125 (2016) 15e2624that all three of the surviving microorganisms are known to
be resistant to antibacterial agents which target the cell membrane
[24].
Incorporation of substrates 14aec into Columbia agar produced
a yellow agar with a slightly yellow ﬂuorescent background, Figs. 7Fig. 7. Culture of various bacterial species with substrates 12aee and 14aec and c
Fig. 8. Observed ﬂuorescence of various bacterial species with substrates 12aee and 14a
numbered plate.and 8. Uptake of the substrates 14aec into the bacterial cell
greatly increased and localized the ﬂuorescence, which was
shown to be suitable for the detection of all bacteria, but it was
impossible to differentiate between b-alanyl aminopeptidase
producing (spots 5, 7, and 9, Table 4) and non-b-alanyl amino-
peptidase producing bacteria. Incorporation of an aryl aldehyde, as
previously discussed, would thus be necessary to shift the emis-
sion wavelengths to one which is distinct from that of the sub-
strates 10aec.
Once again, the substrates 10b and 10c containing longer chain
lengths inhibited bacterial growth, presumably again due to the
disruption of the cell wall. Gram positive and yeast species
appeared to be affected more than Gram negative species.
Preliminary data for the inclusion of 4-chlorobenzaldehyde (4-
CBA) into growth media showed little to no effect on the
observed ﬂuorescence of substrate 14a, Fig. 9. This may be due to a
number of factors, such as the lack of enzymatic cleavage of the
hydrazide bond to release the ﬂuorophore, lack of reaction between
aldehyde and the released hydrazide, failure of the 4-CBA to be
taken up into the cell, a reduction in ﬂuorescence emission due to a
suboptimal wavelength of 365 nm being used to excite the com-
pounds (lex of 465 nm and 467 nm for ﬂuorophore and hydrazone
respectively), or a cleavage of the formed hydrazone bond by en-
zymes expressed by P. aeruginosa, similar to results seen by
Taniyama et al. [25].ontrol on Columbia agar; inoculated colonies correspond to numbered plate.
ec and control on Columbia agar (lex ¼ 365 nm); inoculated colonies correspond to
Table 4
List of microorganisms inoculated onto incubation plates and corresponding spots
(100,000 CFU/spot).
Spot Organism Spot Organism
1 Escherichia coli 11 Streptococcus pyogenes
2 Klebsiella pneumoniae 12 Staphylococcus aureus (MRSA)
3 Providencia rettgeri 13 Staphylococcus aureus
4 Enterobacter cloacae 14 Staphylococcus epidermidis
5 Serratia marcescens 15 Listeria monocytogenes
6 Salmonella typhimurium 16 Enterococcus faecium
7 Pseudomonas aeruginosa 17 Enterococcus faecalis
8 Yersinia enterocolitica 18 Bacillus subtilis
9 Burkholderia cepacia 19 Candida albicans
10 Acinetobacter baumannii 20 Candida glabrata
Fig. 9. Observed ﬂuorescence of Pseudomonas aeruginosa colonies incubated on
Columbia agar in the presence of substrate 14a (100 mg/L) (left) and substrate 14a
(100 mg/L) along with 4-chlorobenzaldehyde (100 mg/L) (right).
J.L. Luo et al. / Dyes and Pigments 125 (2016) 15e26 254. Conclusions
A series of novel ANS and 6-HBI ﬂuorophores 7aee and 10aec
were synthesized and were then coupled to b-alanine to form
substrates 12aee and 14aec for b-alanyl aminopeptidase. Sub-
strates 12d, 14b and 14c, with longer N-substituent chains, were
associated with growth inhibition of all Gram-positive and a ma-
jority of the Gram-negative organisms.
Although preliminary ﬂuorescence data suggested that the ANS
ﬂuorophores 9aee would display favourable ﬂuorescence charac-
teristics, with a bathochromic shift of ~93 nm from the substrates
12aee, as a result of quenching by the medium, Columbia agar
incorporating these substrates did not appear to selectively differ-
entiate between b-alanyl aminopeptidase producing and non-b-
alanyl aminopeptidase producing bacteria. The use of other media
or detection formats may, however, alleviate this issue and thus
allow for their use in bacterial detection.
The increased ﬂuorescence intensity upon localization of sub-
strate 14a into all the Gram negative and 7/8 Gram positive bacteria
(with the exception of Streptococcus pyogenes) does, however
suggest a use for this substrate when the detection of any bacterial
presence is required. For example, as one of the leading causes of
sepsis is bacteraemia, a rapid method for the detection of viable
bacteria in blood would enable the timely administration of anti-
bacterial agents. This would help to reduce the prevalence of
mortality associated with sepsis (10e20% fatality rate), its pro-
gression to severe sepsis (20e50% fatality rate), and, ultimately,
septic shock (40e80% fatality rate). In the US in the period
1999e2008, the leading bacterial causes of severe sepsis were
Gram negative (51.5%) organisms [26], with the most common
being Escherichia coli (20%), and Pseudomonas species (9%). Gram-
positive organisms were responsible for 45.6% of severe sepsis
cases, with methicillin-sensitive S. aureus (28%) being the mostcommon. Of the cases in which E. coli was present, 16% resulted in
mortality, while methicillin-sensitive S. aureus (MSSA) bacteraemia
had a mortality rate of 31% [27].
The ﬂuorophore 10aec was also reacted with a series of para-
substituted benzaldehydes and cinnamaldehyde to alter the ﬂuo-
rescence of the ﬂuorophore. Addition of electron-donating para-
substituted benzaldehydes appeared to form hydrazones 20aec
with the desired emission wavelengths, although the intensities of
emission were severely reduced. Preliminary data with the inclu-
sion of substrate 14awith 4-chlorobenzaldehyde in Columbia agar
showed little to no effect on the observed intensity of ﬂuorescence,
and further work must be undertaken to ascertain the mechanism
behind these observations. Although the synthesized hydrazones
17e21 did not produce the desired characteristics for incorpora-
tion into media, future work should also examine the effects of
more strongly electron-donating aldehydes with less rotatable
bonds.
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